The possibility of specific protection against bovine leukaemia virus infection and bovine leukaemia with inactivated BLV.
D000818:Animals; D002417:Cattle; D002418:Cattle Diseases / Q000276:immunology / Q000517:prevention & control*; D007938:Leukemia / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D001909:Leukemia Virus, Bovine / Q000187:drug effects / Q000276:immunology*; D012190:Retroviridae / Q000276:immunology*; D012756:Sheep; D012757:Sheep Diseases / Q000276:immunology / Q000517:prevention & control*; D014412:Tumor Virus Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D014611:Vaccination / Q000662:veterinary*; D014613:Vaccines, Attenuated / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology*
D014613:Vaccines, Attenuated; D014765:Viral Vaccines